Can’t find what you’re looking for? Just contact us and we’ll get back to you.
Empower your organization with a suite of forecasting tools designed to enhance decision-making and refine your commercial strategy.
Discover >
Streamline your business development and licensing strategies with actionable insights and informed decision making, supported by gold-standard data.
Enhance asset management with powerful tools that enable data-driven decisions and optimize your portfolio strategy for sustainable growth.
Stay ahead of the competition by leveraging competitive intelligence solutions to monitor market trends, anticipate competitor actions, and make strategic data-driven decisions.
Size markets, pressure-test assumptions, and build stronger client recommendations with trusted pharma and biotech forecasts, sales data, and therapy area intelligence.
Identify high-potential biopharma opportunities, strengthen pitches, and bring sharper market evidence into every client conversation.
Support client strategy across pipeline assessment, asset prioritization, launch planning, and long-term portfolio growth with evidence that your teams can defend.
Track competitor moves, regulatory shifts, market dynamics, and emerging trends so your teams can advise clients with greater speed, clarity and confidence.
Build sharper valuation narratives for pharma and biotech M&A, IPOs and capital raising with trusted market data, forecasts, and evidence-backed insight.
Screen emerging pharma and biotech opportunities, assess asset potential, and track the market signals that could shape portfolio growth.
Assess pharma and biotech targets, pressure-test commercial assumptions, and support diligence with trusted market, product and competitor intelligence.
Track catalysts, forecast revisions, regulatory events, and competitive shifts that could affect pharma and biotech company valuations.
World Preview 2026 Webinar
2026 Preview
Obesity and GLP-1 Dealmaking: Strategic Trends and Market Signals
How AI is transforming forecasting in pharma
Portfolio Tactics to Scale the $300bn Patent Cliff
Changing Pharma: What’s Reshaping the Industry
Press Release
June 25, 2026
Evaluate Recognized for Artificial Intelligence Innovation in 9th Annual AI Breakthrough Awards Program
June 23, 2026
Evaluate Releases Annual World Preview Report Revealing Updated Market Forecasts for the Pharmaceutical Industry
March 12, 2026
Evaluate Releases 2026 Orphan Drug Report
March 18, 2025
Norstella Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2025
October 8, 2024
Norstella Introduces NorstellaLinQ, the Biopharma Industry’s First Fully Integrated Data Asset
July 10, 2024
Evaluate Releases 2030 Forecasts for Global Pharmaceutical Market
April 24, 2024
Evaluate’s 2024 Orphan Drug Report Signals Slow Down in Growth
March 5, 2024
Inpart and Evaluate Announce Strategic Partnership to Optimise Biopharma Dealmaking
January 10, 2024
Evaluate, a Norstella Company, Announces Acquisition of J+D Forecasting
October 3, 2023
Evaluate Launches CDMO Intelligence Solution to Support Rapidly Expanding Pharmaceutical CDMO Market
Event
January 12
-
July 15
JP Morgan Global Healthcare Conference
November 17
Evaluate Financing Forum
November 9
November 11
Bio-Europe Fall
September 16
September 17
Pharma CI USA
June 22
June 25
Booth #4819
BIO International Convention
April 29
April 30
Pharma CI Europe
March 26
Mass Bio State of Possible conference
March 23
March 25
Booth #70
Bio-Europe Spring
January 15
BioTech Showcase
November (TBC)
Customer Event: Financing Forum
We work with healthcare and business reporters globally.Learn how Evaluate’s data and expert insights enhance your story.
